Neural Upregulation in Interstitial Cystitis

Urology

Volumn 69, Issue 4 SUPPL., 2007, Pages

  Nazif, Omar ^a   Teichman, Joel M H ^a   Gebhart, G F ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NERVE GROWTH FACTOR BETA SUBUNIT; PHOSPHODIESTERASE; PRODYNORPHIN; PROTEIN C FOS; PROTEINASE ACTIVATED RECEPTOR; PURINE P2X3 RECEPTOR; TRYPTASE;

ARTICLE; BRAIN STEM; HUMAN; INTERSTITIAL CYSTITIS; NERVE CELL; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; STRESS;

AFFERENT PATHWAYS; ANIMALS; BRAIN STEM; CYSTITIS, INTERSTITIAL; GENE EXPRESSION REGULATION; HUMANS; HYPERESTHESIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; NERVE FIBERS, UNMYELINATED; NERVE TISSUE PROTEINS; NEUROGENIC INFLAMMATION; NEURONS; NF-KAPPA B; PAIN; PAIN THRESHOLD; POTASSIUM; SIGNAL TRANSDUCTION; SPINAL CORD; STRESS; URINARY BLADDER;

EID: 34247240952     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.08.1108     Document Type: Article

References (129)

1. Parsons C.L., and Koprowski P.F. Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 37 (1991) 207-212
2. Steinkohl W.B., and Leach G.E. Urodynamic findings in interstitial cystitis. Urology 34 (1989) 399-401
3. Ottem D.P., and Teichman J.M.H. What is the value of cystoscopy with hydrodistension for interstitial cystitis?. Urology 66 (2005) 494-499
4. Hand J.R. Interstitial cystitis: report of 223 cases (204 women and 19 men). J Urol 61 (1949) 291-310
5. Christmas T.J., Rode J., Chapple C.R., et al. Nerve fibre proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol 416 (1990) 447-451
6. Sengupta J.N., and Gebhart G.F. Characterization of mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat. J Neurophysiol 71 (1994) 2046-2060
7. Su X., Sengupta J.N., and Gebhart G.F. Effects of opioids on mechanosensitive pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 77 (1997) 1566-1580
8. Pauwels E., De Wachter S., and Wyndaele J.J. Normality of bladder filling studied in symptom-free middle-aged women. J Urol 171 (2004) 1567-1570
9. Shea V.K., Cai R., Crepps B., et al. Sensory fibers of the pelvic nerve innervating the rat's urinary bladder. J Neurophysiol 84 (2000) 1924-1933
10. Parsons C.L., Greenberger M., Gabal L., et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 159 (1998) 1862-1867
11. Slobodov G., Feloney M., Gran C., et al. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 171 (2004) 1554-1558
12. Letourneau R., Sant G.R., el-Mansoury M., et al. Activation of bladder mast cells in interstitial cystitis. Int J Tissue React 14 (1992) 307-312
13. Parsons C.L., Lilly J.D., and Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145 (1991) 732-735
14. Messing E.M., and Stamey T.A. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 12 (1978) 381-392
15. Lavelle J.P., Apodaca G., Meyers S.A., et al. Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis. Am J Physiol 274 (1998) F208-F214
16. Parsons C.L., Stauffer C., and Schmidt J.D. Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208 (1980) 605-607
17. Parsons C.L., Boychuk D., Jones S., et al. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143 (1990) 139-142
18. Lilly J.D., and Parsons C.L. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 171 (1990) 493-496
19. Teichman J.M., and Nielsen-Omeis B.J. Potassium leak test predicts outcome in interstitial cystitis. J Urol 161 (1999) 1791-1796
20. Parsons C.L. Potassium sensitivity test. Tech Urol 2 (1996) 171-173
21. Parsons C.L., Stein P.C., Bidair M., et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13 (1994) 515-520
22. Parsons C.L., Zupkas P., and Parsons J.K. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology 57 (2001) 428-432
23. Theoharides T.C., and Cochrane D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 146 (2004) 1-12
24. Larsen S., Thompson S.A., Hald T., et al. Mast cells in interstitial cystitis. Br J Urol 54 (1982) 283-286
25. Kastrup J., Hald T., Larsen S., et al. Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol 55 (1983) 495-500
26. Feltis J.T., Perez-Marrero R., and Emerson L.E. Increased mast cells of the bladder in suspected cases of interstitial cystitis: a possible disease marker. J Urol 138 (1987) 42-43
27. Aldenborg F., Fall M., and Enerback L. Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis. Immunology 58 (1986) 411-416
28. Lynes W.L., Flynn S.D., Shortliffe L.D., et al. Mast cell involvement in interstitial cystitis. J Urol 138 (1987) 746-752
29. Tomaszewski J.E., Landis J.R., Russack V., et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the Interstitial Cystitis Database Study. Urology 57 suppl 6A (2001) 67-81
30. Christmas T.J., and Rode J. Characteristics of mast cells in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol 68 (1991) 473-478
31. Boucher W., el-Mansoury M., Pang X., et al. Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol 76 (1995) 94-100
32. el-Mansoury M., Boucher W., Sant G.R., et al. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol 152 (1994) 350-353
33. Dundore P.A., Schwartz A.M., and Semerjian H. Mast cell counts are not useful in the diagnosis of nonulcerative interstitial cystitis. J Urol 155 (1996) 885-887
34. Theoharides T.C., Kempuraj D., and Sant G.R. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 57 suppl 6A (2001) 47-55
35. Marchand J.E., Sant G.R., and Kream R.M. Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol 81 (1998) 224-228
36. Pang X., Marchand J., Sant G.R., et al. Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 75 (1995) 744-750
37. Bjorling D.E., and Wang Z.-Y. Estrogen and neuroinflammation. Urology 57 suppl 6A (2001) 40-46
38. Theoharides T.C., Donelan J.M., Papadopoulou N., et al. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 25 (2004) 563-568
39. Wesselmann U. Neurogenic inflammation and chronic pelvic pain. World J Urol 19 (2001) 180-185
40. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49 suppl 5A (1997) 14-40
41. Steers W.D., and Tuttle J.B. Neurogenic inflammation and nerve growth factor: possible roles in interstitial cystitis. In: Sant G.R. (Ed). Interstitial Cystitis (1997), Lippincott-Raven, Philadelphia 67-75
42. Lowe E.M., Anand P., Terenghi G., et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79 (1997) 572-577
43. Saban M.R., Hellmich H., Nguyen N.B., et al. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 5 (2001) 147-160
44. Oddiah D., Anand P., McMahon S.B., et al. Rapid increase of NGF, BDNF, and NT-3 mRNAs in inflamed bladder. Neuroreport 9 (1998) 1455-1458
45. Vizzard M.A. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 161 (2000) 273-284
46. Dupont M.C., Spitsbergen J.M., Kim K.B., et al. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166 (2001) 1111-1118
47. Saban M.R., Nguyen N.B., Hammond T.G., et al. Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 160 (2002) 2095-2110
48. Ito T., Stein P.C., Parsons C.L., et al. Elevated stress protein in transitional cells exposed to urine from interstitial cystitis patients. Int J Urol 5 (1998) 444-448
49. Okragly A.J., Niles A.L., Saban R., et al. Elevated tryptase, nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 161 (1999) 438-441
50. de Garavilla L., Vergnolle N., Young S.H., et al. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 133 (2001) 975-987
51. Nakahara T., Kubota Y., Mitani A., et al. Protease-activated receptor-2-mediated contraction in the rat urinary bladder: the role of urinary bladder mucosa. Naunyn-Schmiedebergs Arch Pharmacol 367 (2003) 211-213
52. Coelho A.M., Vergnolle N., Guiard B., et al. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 122 (2002) 1035-1047
53. Hoogerwerf W.A., Zou L., Shenoy M., et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 21 (2001) 9036-9042
54. Kirkup A.J., Jiang W., Bunnett N.W., et al. Stimulation of proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetised rats. J Physiol 552 (2003) 589-601
55. Reed D.E., Barajas-Lopez C., Cottrell G., et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 547 (2003) 531-542
56. D'Andrea M.R., Saban M.R., Nguyen N.B., et al. Expression of protease-activated receptor-1, -2, -3 and -4 in control and experimentally inflamed mouse bladder. Am J Pathol 162 (2003) 907-923
57. Vergnolle N. Modulation of visceral pain and inflammation by protease-activated receptors. Br J Pharmacol 141 (2004) 1264-1274
58. Vergnolle N., Wallace J.L., Bunnett N.W., et al. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22 (2001) 146-152
59. Dattilio A., and Vizzard M.A. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. J Urol 173 (2005) 635-639
60. Lamb K., Gebhart G.F., and Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 5 (2004) 150-156
61. Ehren I., Hosseini A., Lundberg J.O., et al. Nitric oxide: a useful gas in the detection of lower urinary tract inflammation. J Urol 162 (1999) 327-329
62. Korting G.E., Smith S.D., Wheeler M.A., et al. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol 161 (1999) 558-565
63. Poljakovic M., Svensson M.L., Svanborg C., et al. Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney. Kidney Int 59 (2001) 893-904
64. Xu X., Cubeddu L.X., and Malave A. Expression of inducible nitric oxide synthase in primary culture of rat bladder smooth muscle cells by plasma from cyclophosphamide-treated rats. Eur J Pharmacol 416 (2001) 1-9
65. 2 production are up-regulated in a rat bladder inflammation model. Eur J Pharmacol 417 (2001) 239-248
66. Lemack G.E., Burkhard F., Zimmern P.E., et al. Physiologic sequelae of partial infravesical obstruction in the mouse: role of inducible nitric oxide synthase. J Urol 161 (1999) 1015-1022
67. Pavcovich L.A., and Valentino R.J. Central regulation of micturition in the rat the corticotropin-releasing hormone from Barrington's nucleus. Neurosci Lett 196 (1995) 185-188
68. Wang X.-C., Saban R., Kaysen J.H., et al. Nuclear factor κB mediates lipopolysaccharide-induced inflammation and gene-expression during antigen-induced bladder inflammation in the urinary bladder. J Urol 163 (2000) 993-998
69. Vizzard M.A. Alterations in spinal cord Fos protein expression induced by bladder stimulation following cystitis. Am J Physiol Regul Integr Comp Physiol 278 (2000) R1027-R1039
70. Kiss S., Yoshiyama M., Cao Y.Q., et al. Impaired response to chemical irritation of the urinary tract in mice with disruption of the preprotachykinin gene. Neurosci Lett 313 (2001) 57-60
71. Escofier N., Boichot E., Germain N., et al. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung. Fundam Clin Pharmacol 13 (1999) 96-101
72. Zimmermann E.M., Li L., Hou Y.T., et al. Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 280 (2001) G1022-G1029
73. Keay S., Zhang C.O., Kagen D.I., et al. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol 158 (1997) 1983-1988
74. DeMeester S.L., Buchman T.G., and Cobb J.P. The heat shock paradox: does NF-κB determine cell fate?. FASEB J 15 (2001) 270-274
75. Andersson K.E. Bladder activation: afferent mechanisms. Urology 59 suppl 5A (2002) 43-50
76. Bielefeldt K., and Gebhart G.F. Visceral pain-basic mechanisms. In: McMahon S., and Koltzenburg M. (Eds). Wall and Melzack's Textbook of Pain. 5th ed. (2005), Elsevier/Churchill Livingstone, Philadelphia 721-736
77. Kuru M. Nervous control of micturition. Physiol Rev 45 (1965) 425-494
78. De Groat W.C., and Steers W.D. Autonomic regulation of urinary bladder and sexual organs. In: Loewy A.D., and Spyer K.M. (Eds). Central Regulation of Autonomic Functions (1990), Oxford University Press, Oxford 310-333
79. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 74 (1994) 95-138
80. Dmitrieva N., Shelton D., Rice A.S., et al. The role of nerve growth factor in a model of visceral inflammation. Neuroscience 78 (1997) 449-459
81. Dubner R., and Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 15 (1992) 96-103
82. Eide F.F., Lowenstein D.H., and Reichardt L.F. Neurotrophins and their receptors-current concepts and implications for neurologic disease. Exp Neurol 121 (1993) 200-214
83. Zagorodnyuk V.P., Costa M., and Brookes S.J. Major classes of sensory neurons to the urinary bladder. Auton Neurosci 30 126-127 (2006) 390-397
84. Xu L., and Gebhart G.F. Mechanosensitivity and sensitization of splanchnic and pelvic nerve innervations of the mouse bladder (2005). http://sfn.scholarone.com/itin2005/index.htm [abstract] Presented at the 35th Annual Meeting of the Society for Neuroscience; November 12-16, Washington, DC. Program No. 294.17. Available at: http://sfn.scholarone.com/itin2005/index.htm. Accessed February 22, 2007.
85. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 45 (1995) 1-98
86. Gebhart G.F., Kuner R., Jones III R.C.W., et al. Visceral hypersensitivity. In: Brune K., and Handwerker H.O. (Eds). Hyperalgesia: Molecular Mechanisms and Clinical Implications, Progress in Pain Research and Management vol 30 (2004), IASP Press, Seattle, WA 87-104
87. Mayer E.A., and Gebhart G.F. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107 (1994) 271-293
88. Janig W., and Koltzenburg M. On the function of spinal primary afferent fibres supplying the colon and urinary bladder. J Auton Nerv Syst 30 suppl (1990) S89-S96
89. McMahon S., and Koltzenburg M. The changing role of primary afferent neurones in pain. Pain 43 (1990) 269-272
90. Cervero F., Laird J.M., and Pozo M.A. Selective changes of receptive field properties of spinal nociceptive neurons induced by noxious visceral stimulation in the cat. Pain 51 (1992) 335-342
91. Garrison D.W., Chandler M.J., and Foreman R.D. Viscerosomatic convergence onto feline spinal neurons from esophagus, heart and somatic fields: effect of inflammation. Pain 49 (1992) 373-382
92. Ruda M.A., and Dubner R. Molecular and biochemical events mediate neuronal plasticity following inflammation and hyperalgesia. In: Willis Jr. W.D. (Ed). Hyperalgesia and Allodynia (1992), Raven Press, New York 311-l325
93. Traub R.J., Pechman P., Iadarola M.J., et al. Fos-like proteins in the lumbosacral spinal cord following noxious and non-noxious colorectal distention in the rat. Pain 49 (1992) 393-403
94. Davies S.N., and Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res 424 (1987) 402-406
95. Woolf C.J., and Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991) 293-299
96. Donaldson L.F., Harmar A.J., McQueen D.S., et al. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Brain Res Mol Brain Res 16 (1992) 143-149
97. Hanesch U., Pfrommer U., Grubb B.D., et al. Acute and chronic phases of unilateral inflammation in rat's ankle are associated with an increase in the proportion of calcitonin gene-related peptide-immunoreactive dorsal root ganglion cells. Eur J Neurosci 5 (1993) 154-161
98. Collo G., North R.A., Kawashima E., et al. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16 (1996) 2495-2507
99. 3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci 12 (1998) 256-268
100. Burnstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194 (1999) 335-342
101. Rong W., Spyer M., and Burnstock G. Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol 541 (2002) 591-600
102. Sun Y., Keay S., De Deyne P.G., et al. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 166 (2001) 1951-1956
103. Wang E.C.Y., Lee J.-M., Ruiz W.G., et al. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115 (2005) 2412-2422
104. Tempest H.V., Dixon A.K., Turner W.H., et al. P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93 (2004) 1344-1348
105. 3 knock out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21 (2001) 5670-5677
106. 2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 567 (2005) 621-639
107. 3-deficient mice. Nature 407 (2000) 1011-1015
108. Pelissier N., Doone G., Boyle M.M., et al. Changes in growth associated with protein (GAP-43), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP-38) in L6-S1 spinal cord and dorsal root ganglia (DRG) following cyclophosphamide (CYP)-induced cystitis. [abstract]. Abstr Soc Neurosci 25 (1999) 1686
109. Vizzard M.A., and Boyle M.M. Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis. Brain Res 844 (1999) 174-187
110. Vizzard M.A., Erdman S.L., and de Groat W.C. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol 370 (1996) 191-202
111. Jennings L.J., and Vizzard M.A. Cyclophosphamide-induced inflammation of the urinary bladder alters electrical properties of small diameter afferent neurons from dorsal root ganglia. [abstract]. FASEB J 13 (1999) A57
112. Yoshimura N., and de Groat W.C. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 19 (1999) 4644-4653
113. Dang K., Bielefeldt K., and Gebhart G.F. Differential responses of bladder lumbosacral and thoracolumbar dorsal root ganglion neurons to purinergic agonists, protons and capsaicin. J Neurosci 25 (2005) 3973-3984
114. Birder L.A., Nakamura Y., Kiss S., et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nature Neurosci 5 (2002) 856-860
115. Gebhart G.F. Descending modulation of pain. Neurosci Biobehav Rev 27 (2004) 729-737
116. Urban M.O., and Gebhart G.F. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A 96 (1999) 7687-7692
117. Hurley R.W., and Hammond D.L. The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20 (2000) 1249-1259
118. Coutinho S.V., Urban M.O., and Gebhart G.F. The role of CNS NMDA receptors and nitric oxide in visceral hyperalgesia. Eur J Pharmacol 429 (2001) 319-325
119. Friedrich A., and Gebhart G.F. Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla. Pain 104 (2003) 93-101
120. Lutgendorf S.K., Kreder K.J., Rothrock N.E., et al. Stress and symptomatology in patients with interstitial cystitis: a laboratory stress model. J Urol 164 (2000) 1265-1269
121. Sternberg E.M., Chrousos G.P., Wilder R.L., et al. The stress response and the regulation of inflammatory disease. Ann Intern Med 117 (1992) 854-866
122. Basbaum A.I., and Levine J.D. The contribution of the nervous system to inflammation and inflammatory disease. Can J Physiol Pharmacol 69 (1991) 647-651
123. Spanos C., Pang X., Ligris K., et al. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 157 (1997) 669-672
124. Lutgendorf S.K., Kreder K.J., Rothrock N.E., et al. Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol 167 (2002) 1338-1343
125. Lutgendorf S.K., Latini J.M., Rothrock N., et al. Autonomic response to stress in interstitial cystitis. J Urol 172 (2004) 227-231
126. Rothrock N.E., Lutgendorf S.K., Kreder K.J., et al. Stress and symptoms in patients with interstitial cystitis: a life cycle model. Urology 57 (2001) 422-427
127. Stein P.C., Torri A., and Parsons C.L. Elevated urinary norepinephrine in interstitial cystitis. Urology 53 (1999) 1140-1143
128. Buffington C.A. Plasma catecholamine concentration in cats with interstitial cystitis. [abstract]. J Urol 163 suppl (2000) 59
129. Driscoll A., and Teichman J.M.H. How do patients with interstitial cystitis present?. J Urol 166 (2001) 2118-2120